Replies to post #13464 on Ayala Pharmaceuticals Inc (ADXS)

[Stockdoggy]

Thank you for taking the time to research executive compensation and for sharing it with the board. It seems our CEO may not be so bad after all. In fact, it seems as though he is somewhat extraordinary in accepting shares over cash.

I think many are just looking for a punching bag to take out their frustrations over the share price, and DO is the chosen target. Others (myself included, at times) tend to be easily influenced and are swayed into thinking the CEO is a greedy villain and should be replaced. It is refreshing to see an opinion backed by facts.

In my opinion, the low share price and corresponding low market cap have nothing to do with the whole issue of excessive compensation for management. The bottom fell out of biotechs in general last year and ADXS suffered along with the rest. Several bios I own have not recovered nearly as well as Advaxis.

[Julius_Kelp]

Thanks for the analysis Meishairwin.

[fbg0316]

Meishairwin, great analysis, thanks for sharing and giving more context to the issue. Looking forward to seeing shareholder value generation at some point moving forward then investors will be happy and more supportive of the management bonus comp structure.

[Julius_Kelp]

Would someone please "sticky" Meishairwin's excellent analysis? Thank you.

[Traderbx]

Good post.